Published in Lancet on March 24, 2016
A Functional Role for Antibodies in Tuberculosis. Cell (2016) 2.17
The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling. PLoS Med (2016) 0.87
Interactions between Type 1 Interferons and the Th17 Response in Tuberculosis: Lessons Learned from Autoimmune Diseases. Front Immunol (2017) 0.83
Unbiased Identification of Blood-based Biomarkers for Pulmonary Tuberculosis by Modeling and Mining Molecular Interaction Networks. EBioMedicine (2016) 0.83
Characterization of progressive HIV-associated tuberculosis using 2-deoxy-2-[(18)F]fluoro-D-glucose positron emission and computed tomography. Nat Med (2016) 0.77
Blood transcriptomic diagnosis of pulmonary and extrapulmonary tuberculosis. JCI Insight (2016) 0.77
Longitudinal monitoring of gene expression in ultra-low-volume blood samples self-collected at home. Clin Exp Immunol (2017) 0.76
A 10-Gene Signature for the Diagnosis and Treatment Monitoring of Active Tuberculosis Using a Molecular Interaction-network Approach. EBioMedicine (2017) 0.75
Driving the Way to Tuberculosis Elimination: The Essential Role of Fundamental Research. Clin Infect Dis (2016) 0.75
Current trends and intricacies in the management of HIV-associated pulmonary tuberculosis. AIDS Res Ther (2016) 0.75
The Challenge of Latent TB Infection. JAMA (2016) 0.75
Highly Multiplexed Proteomic Analysis of Quantiferon Supernatants to Identify Biomarkers of Latent Tuberculosis Infection. J Clin Microbiol (2016) 0.75
Systems Immunology of Diabetes-Tuberculosis Comorbidity Reveals Signatures of Disease Complications. Sci Rep (2017) 0.75
Circulating granulysin levels in healthcare workers and latent tuberculosis infection estimated using interferon-gamma release assays. BMC Infect Dis (2016) 0.75
Predicting tuberculosis risk - Authors' reply. Lancet (2016) 0.75
Elevated Circulating Concentrations of Interferon-Gamma in Latent Tuberculosis Infection. Pathog Immun (2016) 0.75
Host-based Peripheral Blood Gene Expression Analysis for the Diagnosis of Infectious Diseases. J Clin Microbiol (2016) 0.75
Clinical Application of Interferon-γ Release Assays for the Prevention of Tuberculosis in Countries with Low Incidence. Pathog Immun (2016) 0.75
MAIT cells are reduced in frequency and functionally impaired in human T lymphotropic virus type 1 infection: Potential clinical implications. PLoS One (2017) 0.75
Predicting active tuberculosis progression by RNA analysis. Lancet (2016) 0.75
Early Whole Blood Transcriptional Signatures Are Associated with Severity of Lung Inflammation in Cynomolgus Macaques with Mycobacterium tuberculosis Infection. J Immunol (2016) 0.75
BLR1 and FCGR1A transcripts in peripheral blood associate with the extent of intrathoracic tuberculosis in children and predict treatment outcome. Sci Rep (2016) 0.75
Transcriptomic Biomarkers for Tuberculosis: Evaluation of DOCK9. EPHA4, and NPC2 mRNA Expression in Peripheral Blood. Front Microbiol (2016) 0.75
Predicting tuberculosis risk. Lancet (2016) 0.75
Risk prediction of pulmonary tuberculosis using genetic and conventional risk factors in adult Korean population. PLoS One (2017) 0.75
What We Have Learned and What We Have Missed in Tuberculosis Pathophysiology for a New Vaccine Design: Searching for the "Pink Swan". Front Immunol (2017) 0.75
Heterogeneity in tuberculosis. Nat Rev Immunol (2017) 0.75
Regulatory T Cells and Pro-inflammatory Responses Predominate in Children with Tuberculosis. Front Immunol (2017) 0.75
Tuberculosis in Children. Pediatr Clin North Am (2017) 0.75
RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet (2009) 58.77
Fast and SNP-tolerant detection of complex variants and splicing in short reads. Bioinformatics (2010) 17.53
NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res (2012) 15.84
The genetic structure and history of Africans and African Americans. Science (2009) 10.65
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature (2010) 10.37
The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol (2009) 8.13
Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med (2004) 5.90
Out-of-Africa migration and Neolithic coexpansion of Mycobacterium tuberculosis with modern humans. Nat Genet (2013) 3.89
The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol (1974) 3.72
Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk. Nature (2014) 3.60
Simple decision rules for classifying human cancers from gene expression profiles. Bioinformatics (2005) 3.24
Immunological biomarkers of tuberculosis. Nat Rev Immunol (2011) 2.88
New feature subset selection procedures for classification of expression profiles. Genome Biol (2002) 2.54
Hypervirulent M. tuberculosis W/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway. J Interferon Cytokine Res (2005) 2.50
The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis. Pediatr Infect Dis J (2011) 2.47
Common patterns and disease-related signatures in tuberculosis and sarcoidosis. Proc Natl Acad Sci U S A (2012) 2.42
Human gene expression profiles of susceptibility and resistance in tuberculosis. Genes Immun (2010) 2.38
Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses. Science (2013) 2.34
Diagnosis of childhood tuberculosis and host RNA expression in Africa. N Engl J Med (2014) 2.12
Systems scale interactive exploration reveals quantitative and qualitative differences in response to influenza and pneumococcal vaccines. Immunity (2013) 2.08
Lifetime risks, incubation period, and serial interval of tuberculosis. Am J Epidemiol (2000) 2.05
Random forests for genomic data analysis. Genomics (2012) 1.98
Detection of tuberculosis in HIV-infected and -uninfected African adults using whole blood RNA expression signatures: a case-control study. PLoS Med (2013) 1.91
Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancers. PLoS One (2013) 1.86
Functional correlations of pathogenesis-driven gene expression signatures in tuberculosis. PLoS One (2011) 1.73
Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response. J Infect Dis (2012) 1.69
Revisiting rates of reactivation tuberculosis: a population-based approach. Am J Respir Crit Care Med (2010) 1.69
Detectable changes in the blood transcriptome are present after two weeks of antituberculosis therapy. PLoS One (2012) 1.68
Immunogenicity of novel DosR regulon-encoded candidate antigens of Mycobacterium tuberculosis in three high-burden populations in Africa. Clin Vaccine Immunol (2009) 1.67
Genome-wide expression profiling identifies type 1 interferon response pathways in active tuberculosis. PLoS One (2012) 1.58
The tuberculin skin test versus QuantiFERON TB Gold® in predicting tuberculosis disease in an adolescent cohort study in South Africa. PLoS One (2011) 1.42
A helicopter perspective on TB biomarkers: pathway and process based analysis of gene expression data provides new insight into TB pathogenesis. PLoS One (2013) 1.31
Estimated rate of reactivation of latent tuberculosis infection in the United States, overall and by population subgroup. Am J Epidemiol (2013) 1.27
TB incidence in an adolescent cohort in South Africa. PLoS One (2013) 1.22
Type I IFN signaling triggers immunopathology in tuberculosis-susceptible mice by modulating lung phagocyte dynamics. Eur J Immunol (2014) 1.15
Differential gene expression of activating Fcγ receptor classifies active tuberculosis regardless of human immunodeficiency virus status or ethnicity. Clin Microbiol Infect (2013) 1.04
Statistical considerations for analysis of microarray experiments. Clin Transl Sci (2011) 1.00
Childhood tuberculosis and its early diagnosis. Clin Biochem (2004) 0.96
Biomarkers Can Identify Pulmonary Tuberculosis in HIV-infected Drug Users Months Prior to Clinical Diagnosis. EBioMedicine (2014) 0.93
Top scoring pairs for feature selection in machine learning and applications to cancer outcome prediction. BMC Bioinformatics (2011) 0.91
Platelets direct monocyte differentiation into epithelioid-like multinucleated giant foam cells with suppressive capacity upon mycobacterial stimulation. J Infect Dis (2014) 2.69
Progress in tuberculosis vaccine development and host-directed therapies--a state of the art review. Lancet Respir Med (2014) 1.42
Safety and immunogenicity of candidate vaccine M72/AS01E in adolescents in a TB endemic setting. Vaccine (2015) 0.95
Antigen export during liver infection of the malaria parasite augments protective immunity. MBio (2014) 0.87
Interactions between Type 1 Interferons and the Th17 Response in Tuberculosis: Lessons Learned from Autoimmune Diseases. Front Immunol (2017) 0.83
TLR3 regulates mycobacterial RNA-induced IL-10 production through the PI3K/AKT signaling pathway. Cell Signal (2014) 0.83
Versatile myeloid cell subsets contribute to tuberculosis-associated inflammation. Eur J Immunol (2015) 0.81
A Mouse Model of Latent Tuberculosis Infection to Study Intervention Strategies to Prevent Reactivation. PLoS One (2016) 0.81
Vaccination Against Tuberculosis With Whole-Cell Mycobacterial Vaccines. J Infect Dis (2016) 0.81
Detection of IgG1 antibodies against Mycobacterium tuberculosis DosR and Rpf antigens in tuberculosis patients before and after chemotherapy. Tuberculosis (Edinb) (2015) 0.79
Syndecans promote mycobacterial internalization by lung epithelial cells. Cell Microbiol (2016) 0.79
Rewiring cellular metabolism via the AKT/mTOR pathway contributes to host defence against Mycobacterium tuberculosis in human and murine cells. Eur J Immunol (2016) 0.79
Comparative Systems Analyses Reveal Molecular Signatures of Clinically tested Vaccine Adjuvants. Sci Rep (2016) 0.75
Human and Mouse Hematopoietic Stem Cells Are a Depot for Dormant Mycobacterium tuberculosis. PLoS One (2017) 0.75
Ebola vaccine R&D: Filling the knowledge gaps. Sci Transl Med (2015) 0.75
Cell-type deconvolution with immune pathways identifies gene networks of host defense and immunopathology in leprosy. JCI Insight (2016) 0.75
Developmental transcriptome of resting cell formation in Mycobacterium smegmatis. BMC Genomics (2016) 0.75
Reply to Crawford. J Infect Dis (2015) 0.75
TBVAC2020: Advancing Tuberculosis Vaccines from Discovery to Clinical Development. Front Immunol (2017) 0.75
The Recombinant Bacille Calmette-Guérin Vaccine VPM1002: Ready for Clinical Efficacy Testing. Front Immunol (2017) 0.75
A dose-dependent plasma signature of the safety and immunogenicity of the rVSV-Ebola vaccine in Europe and Africa. Sci Transl Med (2017) 0.75
Host blood RNA signatures predict the outcome of tuberculosis treatment. Tuberculosis (Edinb) (2017) 0.75
Mycobacterium tuberculosis infection modulates adipose tissue biology. PLoS Pathog (2017) 0.75
Molecular Signatures of Immunity and Immunogenicity in Infection and Vaccination. Front Immunol (2017) 0.75
Comprehensive definition of human immunodominant CD8 antigens in tuberculosis. NPJ Vaccines (2017) 0.75
Pulmonary immune responses to Mycobacterium tuberculosis in exposed individuals. PLoS One (2017) 0.75